Myocardial Ischemia

L. David Hillis, Eugene Braunwald

Resultado de la investigación: Review articlerevisión exhaustiva

34 Citas (Scopus)

Resumen

Pharmacologic Interventions A number of pharmacologic agents reduce myocardial ischemic injury in the laboratory animal, and some have been used in limited numbers of patients. The activation of the complement system via its alternate pathway, a shift that characterizes ischemic tissue, releases leukotactic factors and increases capillary permeability, leading to interstitial edema. As a result, the microvasculature is compressed, further diminishing blood flow to the ischemic area.18,233,234 Cobra-venom factor, a protein that enzymatically cleaves C3 and prevents the effects of the complement system, reduces myocardial injury.196,197 Similarly, the kallikrein system enhances leukotactic activity, capillary permeability, interstitial edema and proteolytic activity.

Idioma originalEnglish (US)
Páginas (desde-hasta)1093-1096
Número de páginas4
PublicaciónNew England Journal of Medicine
Volumen296
N.º19
DOI
EstadoPublished - may. 12 1977
Publicado de forma externa

ASJC Scopus subject areas

  • Medicine(all)

Huella

Profundice en los temas de investigación de 'Myocardial Ischemia'. En conjunto forman una huella única.

Citar esto